Skip to main content

Table 2 Main outcomes in all patients and specific sub-groups

From: Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients

  N 2y PFS p 2y OS p 2y RI p 1y NRM p
All 18 45%   66%   38%   14%  
CR vs PR 119 vs 79 55% vs 29% 0.001 74% vs 55% 0.03 27% vs 55% <  0.001 13% vs 16% 0.8
Haplo vs HLAid 65 vs 133 63% vs 37% 0.03 67% vs 63% 0.6 24% vs 44% 0.008 13% vs 15% 0.9
CR Haplo vs 37 75% < 0.001a 83% 0.1 6% < 14% 0.8
CR HLAid vs 82 47%   67%   34% 0.001a 13%  
PR Haplo vs 28 44%   58%   44%   11%  
PR HLAid 51 22%   54%   60%   18%  
  1. CR complete remission, PR partial remission, PFS progression free survival, OS overall survival, RI relapse incidence
  2. atrend
\